Cargando…
Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease
BACKGROUND: Multiple myeloma is a hematologic malignancy characterized by the accumulation of monoclonal plasma cells in the bone marrow. A common manifestation of the disease is myeloma bone disease (MBD), which is caused by increased osteoclastic bone resorption and decreased bone formation. The c...
Autores principales: | Fu, Rong, Liu, Hui, Zhao, Sijie, Wang, Yihao, Li, Lijuan, Gao, Shan, Ruan, Erbao, Wang, Guojin, Wang, Huaquan, Song, Jia, Shao, Zonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268854/ https://www.ncbi.nlm.nih.gov/pubmed/25520585 http://dx.doi.org/10.1186/s12935-014-0132-6 |
Ejemplares similares
-
Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014) -
Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function
por: Chen, Jin, et al.
Publicado: (2019) -
De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017) -
Granulocyte Transfusion Combined with Granulocyte Colony Stimulating Factor in Severe Infection Patients with Severe Aplastic Anemia: A Single Center Experience from China
por: Wang, Huaquan, et al.
Publicado: (2014) -
Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy
por: Wang, Huaquan, et al.
Publicado: (2015)